A carregar...
A phase II study of laquinimod in Crohn's disease
OBJECTIVE: Laquinimod is an oral therapeutic agent under investigation for the treatment of Crohn's disease (CD), Huntington's disease, lupus nephritis and multiple sclerosis. This dose escalation study evaluated the safety and efficacy of laquinimod as induction therapy in patients with a...
Na minha lista:
| Publicado no: | Gut |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4515993/ https://ncbi.nlm.nih.gov/pubmed/25281416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2014-307118 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|